Education regarding CMSs Initial Price Applicability Year (IPAY) 2029 proposed rule regarding the fixed-dose combination policy which would create significant disincentives for research and development, undermine FDA-recognized distinctions between therapies, and limit patient access to critical treatment options.
2026 · 3rd Quarter (July 1 - Sep 30)
BRISTOL-MYERS SQUIBB COMPANY
Filed by ADVANCED POLICY CONSULTING, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 13, 2026
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- ADVANCED POLICY CONSULTING, LLC
- Filing UUID
- a0aa4b2c-0dd3-4ede-b12a-fc2b07e0f4c8
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.